FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3217732496> ?p ?o ?g. }

• W3217732496 abstract "The COVID-19 pandemic has affected the world extraordinarily. This disease has a potential to cause a significantly severe course of disease leading to respiratory complications, multiple organ failure and possibly death. In the fight against this pandemic-causing disease, medical professionals around the world are searching for pharmacological agents that could treat and prevent disease progression and mortality. To speed the search of promising treatment options, already existing pharmacological agents are repurposed for the potential treatment of COVID-19 and tested in clinical trials. The aim of this literature review is to investigate the efficacy and safety of repurposed pharmacological agents for the treatment of COVID-19 at different pathophysiologic stages of the disease. For this literature review, online-databases PubMed and Google Scholar were utilised. Keywords COVID-19, SARS-CoV-2, pathogenesis, drug targets, pharmacological treatment, cytokine storm, coagulopathy and individual drug names were used. Scientific articles, including reviews, clinical trials, and observational cohorts, were collected and analysed. Furthermore, these articles were examined for references to find more clinical trials testing for the potential treatment of COVID-19. In total, 97 references were used to conduct this research paper.The most beneficial pharmacological agent for the treatment of COVID-19 are corticosteroids, especially dexamethasone, for the treatment of mechanically ventilated COVID-19 patients. Other promising agents are remdesivir for the treatment of patients with COVID-19 pneumonia requiring minimal supplemental oxygen therapy, and IL-6 receptor antagonist monoclonal antibodies in severe COVID-19. Lopinavir/ritonavir, as well as chloroquine or hydroxychloroquine with or without azithromycin demonstrate the least efficacy in the treatment of COVID-19. The clinical benefits of the treatment of a COVID-19-specific coagulopathy with increased dosing of anticoagulation need further research and confirmation of randomised controlled trials.The search for pharmacological treatment of COVID-19 has elicited great controversy. Whereas drugs like chloroquine, hydroxychloroquine, and lopinavir/ritonavir have not shown proven benefit, the agents remdesivir and dexamethasone are recommended for clinical use for the treatment of COVID-19. Further randomised trials for other pharmacological treatment strategies are awaited." @default.
• W3217732496 created "2021-12-06" @default.
• W3217732496 creator A5036353430 @default.
• W3217732496 creator A5055298252 @default.
• W3217732496 date "2021-11-27" @default.
• W3217732496 modified "2023-10-16" @default.
• W3217732496 title "Repurposed pharmacological agents for the potential treatment of COVID-19: a literature review" @default.
• W3217732496 cites W2095807050 @default.
• W3217732496 cites W2150119943 @default.
• W3217732496 cites W2150120685 @default.
• W3217732496 cites W2558496710 @default.
• W3217732496 cites W2725497285 @default.
• W3217732496 cites W2784412824 @default.
• W3217732496 cites W2794125559 @default.
• W3217732496 cites W3001118548 @default.
• W3217732496 cites W3001897055 @default.
• W3217732496 cites W3004280078 @default.
• W3217732496 cites W3004318991 @default.
• W3217732496 cites W3004626187 @default.
• W3217732496 cites W3005212621 @default.
• W3217732496 cites W3006564542 @default.
• W3217732496 cites W3007969569 @default.
• W3217732496 cites W3008461878 @default.
• W3217732496 cites W3008763357 @default.
• W3217732496 cites W3008827533 @default.
• W3217732496 cites W3008884284 @default.
• W3217732496 cites W3009577418 @default.
• W3217732496 cites W3009885589 @default.
• W3217732496 cites W3009912996 @default.
• W3217732496 cites W3010673910 @default.
• W3217732496 cites W3010930696 @default.
• W3217732496 cites W3011127849 @default.
• W3217732496 cites W3012232836 @default.
• W3217732496 cites W3012379316 @default.
• W3217732496 cites W3013054181 @default.
• W3217732496 cites W3013486442 @default.
• W3217732496 cites W3013630838 @default.
• W3217732496 cites W3013800395 @default.
• W3217732496 cites W3013899502 @default.
• W3217732496 cites W3014050022 @default.
• W3217732496 cites W3015141576 @default.
• W3217732496 cites W3015399432 @default.
• W3217732496 cites W3015400158 @default.
• W3217732496 cites W3015631662 @default.
• W3217732496 cites W3017382320 @default.
• W3217732496 cites W3018023298 @default.
• W3217732496 cites W3018517500 @default.
• W3217732496 cites W3019046211 @default.
• W3217732496 cites W3019088743 @default.
• W3217732496 cites W3020239101 @default.
• W3217732496 cites W3022225035 @default.
• W3217732496 cites W3022373008 @default.
• W3217732496 cites W3022564719 @default.
• W3217732496 cites W3023215109 @default.
• W3217732496 cites W3023330307 @default.
• W3217732496 cites W3023346879 @default.
• W3217732496 cites W3023908803 @default.
• W3217732496 cites W3024339709 @default.
• W3217732496 cites W3024845488 @default.
• W3217732496 cites W3024929070 @default.
• W3217732496 cites W3025170810 @default.
• W3217732496 cites W3025795175 @default.
• W3217732496 cites W3027630905 @default.
• W3217732496 cites W3027918021 @default.
• W3217732496 cites W3028989873 @default.
• W3217732496 cites W3029562523 @default.
• W3217732496 cites W3032373213 @default.
• W3217732496 cites W3032677067 @default.
• W3217732496 cites W3034228022 @default.
• W3217732496 cites W3035265089 @default.
• W3217732496 cites W3036398841 @default.
• W3217732496 cites W3039530416 @default.
• W3217732496 cites W3041464116 @default.
• W3217732496 cites W3041789758 @default.
• W3217732496 cites W3043268795 @default.
• W3217732496 cites W3044087915 @default.
• W3217732496 cites W3044095520 @default.
• W3217732496 cites W3044118599 @default.
• W3217732496 cites W3044416430 @default.
• W3217732496 cites W3044711307 @default.
• W3217732496 cites W3045220852 @default.
• W3217732496 cites W3045649158 @default.
• W3217732496 cites W3047117796 @default.
• W3217732496 cites W3048510827 @default.
• W3217732496 cites W3080718665 @default.
• W3217732496 cites W3081721922 @default.
• W3217732496 cites W3081877184 @default.
• W3217732496 cites W3082108964 @default.
• W3217732496 cites W3082246640 @default.
• W3217732496 cites W3082720169 @default.
• W3217732496 cites W3110466220 @default.
• W3217732496 cites W3110844195 @default.
• W3217732496 cites W3130126061 @default.
• W3217732496 cites W3133932534 @default.
• W3217732496 cites W4210642183 @default.
• W3217732496 doi "https://doi.org/10.1186/s12931-021-01885-8" @default.
• W3217732496 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8626754" @default.
• W3217732496 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34838020" @default.
• W3217732496 hasPublicationYear "2021" @default.
• W3217732496 type Work @default.

• next